1. Home
  2. ONMD vs ELUT Comparison

ONMD vs ELUT Comparison

Compare ONMD & ELUT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo OneMedNet Corp

ONMD

OneMedNet Corp

HOLD

Current Price

$0.75

Market Cap

35.9M

Sector

N/A

ML Signal

HOLD

Logo Elutia Inc.

ELUT

Elutia Inc.

HOLD

Current Price

$0.87

Market Cap

42.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ONMD
ELUT
Founded
2006
2015
Country
United States
United States
Employees
23
N/A
Industry
Medical Specialities
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
35.9M
42.5M
IPO Year
N/A
2020

Fundamental Metrics

Financial Performance
Metric
ONMD
ELUT
Price
$0.75
$0.87
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$6.00
AVG Volume (30 Days)
624.7K
53.3K
Earning Date
05-13-2026
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
146.77
EPS
N/A
N/A
Revenue
N/A
$12,293,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$10.83
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.44
$0.50
52 Week High
$4.22
$2.50

Technical Indicators

Market Signals
Indicator
ONMD
ELUT
Relative Strength Index (RSI) 60.57 39.85
Support Level $0.77 $0.51
Resistance Level $0.93 $1.00
Average True Range (ATR) 0.09 0.06
MACD 0.01 -0.00
Stochastic Oscillator 84.81 31.58

Price Performance

Historical Comparison
ONMD
ELUT

About ONMD OneMedNet Corp

OneMedNet Corp is a healthcare software company with solutions focused on digital medical image management, exchange, and sharing. It is a provider of clinical imaging innovation and curator of regulatory-grade Imaging Real World Data(iRWDTM). Its solutions connect healthcare providers and patients, satisfying a crucial need within the life sciences field, offering direct access to clinical images and the associated contextual patient record. Its technology has provens the commercial and regulatory viability of imaging Real World Data, an emerging market, and provides regulatory-grade, image-centric iRWDTM. Geographically, it operates in Americas, Europe and Middle East, and Asia Pacific. It derives maximum revenue from Europe and Middle East.

About ELUT Elutia Inc.

Elutia Inc develops proprietary drug-eluting biomatrix products for use in surgical reconstruction and related applications. These products are designed to improve the interaction between implanted medical devices and patients. Its products include CanGaroo, designed for implantable electronic devices, and SimpliDerm, used in soft tissue repair, with functions related to implant support and wound management. The company operates in two segments: Women's Health and Cardiovascular. The majority of revenue is derived from the Women's Health segment.

Share on Social Networks: